NCT03637075View on ClinicalTrials.gov

Raclopride-PET/MRT

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

February 20, 2017

Primary Completion Date

June 6, 2023

Study Completion Date

December 31, 2023

Conditions
Diabetes Mellitus, Type 2
Interventions
OTHER

intranasal insulin

intranasal administration of insulin (160 IU)

OTHER

Placebo

placebo intranasal administration

Trial Locations (1)

72076

University of Tuebingen, Department of Internal Medicine IV, Tübingen

All Listed Sponsors
lead

University Hospital Tuebingen

OTHER

NCT03637075 - Raclopride-PET/MRT | Biotech Hunter | Biotech Hunter